N,N'-Diacetyl-L-cystine

Suppliers

Names

[ CAS No. ]:
5545-17-5

[ Name ]:
N,N'-Diacetyl-L-cystine

[Synonym ]:
N,N`-Diacetyl-L-cystine
N,N'-Diacetyl-L-cystine
N,N'-diacetyl-cystine
N-acetyl-L-cystine
ACETYL-L-CYSTINE
DiNAC
L-Cystine, N,N'-diacetyl-
Cystine, N,N'-diacetyl-, L-
diacetylcysteine
L-Cystine,N,N'-diacetyl
N,N''-Diacetyl-L-cysteine
N-ACETYL CYSTINE

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
715.5±60.0 °C at 760 mmHg

[ Melting Point ]:
55-72ºC

[ Molecular Formula ]:
C10H16N2O6S2

[ Molecular Weight ]:
324.374

[ Flash Point ]:
386.5±32.9 °C

[ Exact Mass ]:
324.044983

[ PSA ]:
183.40000

[ LogP ]:
0.46

[ Vapour Pressure ]:
0.0±5.0 mmHg at 25°C

[ Index of Refraction ]:
1.583

[ Storage condition ]:
-15°C

[ Stability ]:
Moisture Sensitive

Safety Information

[ HS Code ]:
29225090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Acetylcysteine(N-acetylcysteine)
  • L-Cystine
  • Ethanoic anhydride
  • L-cysteine
  • azane,cyclohexanamine,platinum(4+),dichloride,dihydroxide
  • Dimethyl diacetyl cystinate
  • N,N'-diacetyl-L-cystine dipropyl ester
  • S-nitroso-N-acetylcysteine

DownStream

  • L-Cystine
  • Dimethyl diacetyl cystinate
  • Ammonia

Articles

Influence of N,N'-diacetyl-L-cystine on D-galactosamine/lipopolysaccharide induced immunological liver failure in mice.

Yao Xue Xue Bao 39(10) , 782-6, (2004)

To study the therapeutic effects of N,N'-diacetyl-L-cystine (DiNAC) on immunological liver failure.Serum ALT, AST and T cell subsets in peripheral blood of the experimental animals during the trial pe...

Immunomodulation with DiNAC-- a new approach to the treatment of atherosclerosis?

Expert Opin. Investig. Drugs 11(5) , 717-20, (2002)

Not all antioxidants reduce atherosclerosis. This may be because atherosclerosis has an autoimmune, inflammatory pathogenesis. As probucol is both an antioxidant and an immunomodulatory drug, it may b...

The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism.

Atherosclerosis 196(1) , 275-82, (2008)

To investigate if the immunomodulator drug DINAC (1) affects arterial dimensions in asymptomatic patients with hypercholesterolemia, (2) has effects on leucocyte markers of inflammation and (3) has in...


More Articles

Related Compounds

  • N,N'-diacetyl-L-cystine dipropyl ester
  • N,N'-Diacetyl-L-cystine dimethyl ester
  • N,N'-diacetyl-L-cystine bismethylamide
  • N,N'-Diacetyl-L-cystine Bis(tert-Butyl) Diester
  • N,N'-Didansyl-L-cystine
  • N,N'-dipalmitoyl-L-cystine
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • N-(azepan-3-ylmethyl)methanesulfonamide
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • N-[(1-ethyl-1H-imidazol-5-yl)methyl]hydroxylamine
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • 3-Chloro-5-methoxy-4-methylbenzoic acid
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde